Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 209 (RNA5SP209)

Target
RNA5SP209
Molecular classification
Other, processed pseudogene (of ribosomal RNA type)
01

Overview

RNA, 5S ribosomal pseudogene 209 (RNA5SP209) is a processed pseudogene in the human genome related to the functional 5S ribosomal RNA genes[2][6]. Unlike canonical 5S rRNA, which is an essential structural component of the large ribosomal subunit necessary for ribosome function and protein synthesis[1][3][5], this pseudogene does not produce functional rRNA and is not associated with any known biological or clinical function[2][6]. Processed pseudogenes like RNA5SP209 are typically generated through reverse transcription and integration of RNA transcripts back into the genome, lacking introns and regulatory elements required for functional gene expression[6]. There is currently no evidence linking RNA5SP209 to therapeutic targeting, disease, or use as a biomarker, and it should not be classified as a receptor, enzyme, transporter, or therapeutic target. In summary, RNA5SP209 is a pseudogene with no known function, disease association, or druggability. Any reference to it as a therapeutic target is incorrect.

Other names
RN5S209RNA5SP209RNA, 5S ribosomal 209
02

Biological functions

Generally, pseudogenes do not encode functional proteins.Some pseudogenes may play regulatory roles at the RNA level, such as acting as decoys for microRNAs or RNA-binding proteins, or producing antisense transcripts involved in gene regulation, but no such function has been described for RNA5SP209 specifically.
03

Disease associations

No established role in disease for RNA5SP209.Some pseudogenes can influence cancer and other diseases through gene regulation, but there is no evidence that RNA5SP209 does so.

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 209 (RNA5SP209).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 209 (RNA5SP209).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call